Committee for Orphan Medicinal Products (COMP): 6-8 October 2020

Date: 06/10/2020 to 08/10/2020
Location: European Medicines Agency, Amsterdam, the Netherlands
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

How useful was this page?

Add your rating